Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 2
2016 2
2019 1
2020 2
2021 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Anti-PD1-R checkpoint inhibitor related severe relapsing myelitis.
Januel E, Perol L, Arrivé L, Alamowitch S, Fain O, Mekinian A; MINHEMON (French nationwide network of dysimmune disorders associated to hemopathies, neoplasms). Januel E, et al. Among authors: perol l. Acta Neurol Belg. 2021 Dec;121(6):1855-1857. doi: 10.1007/s13760-020-01434-y. Epub 2020 Jul 13. Acta Neurol Belg. 2021. PMID: 32661739 No abstract available.
Loss of immune tolerance to IL-2 in type 1 diabetes.
Pérol L, Lindner JM, Caudana P, Nunez NG, Baeyens A, Valle A, Sedlik C, Loirat D, Boyer O, Créange A, Cohen JL, Rogner UC, Yamanouchi J, Marchant M, Leber XC, Scharenberg M, Gagnerault MC, Mallone R, Battaglia M, Santamaria P, Hartemann A, Traggiai E, Piaggio E. Pérol L, et al. Nat Commun. 2016 Oct 6;7:13027. doi: 10.1038/ncomms13027. Nat Commun. 2016. PMID: 27708334 Free PMC article.
Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study).
Algrin C, Pérol L, Chapiro E, Baseggio L, Maloum K, Settegrana C, Lesesve JF, Siavellis J, Delmer A, Michallet AS, Ferrant E, Feugier P, Tomowiak C, Brion A, Ghez D, Fornecker LM, Ivanoff S, Struski S, Sutton L, Radford-Weiss I, Eclache V, Lefebvre C, Leblond V, Nguyen-Khac F, Roos-Weil D. Algrin C, et al. Among authors: perol l. Haematologica. 2023 Jun 1;108(6):1691-1696. doi: 10.3324/haematol.2022.282162. Haematologica. 2023. PMID: 36546425 Free PMC article. No abstract available.
Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients.
Núñez NG, Tosello Boari J, Ramos RN, Richer W, Cagnard N, Anderfuhren CD, Niborski LL, Bigot J, Meseure D, De La Rochere P, Milder M, Viel S, Loirat D, Pérol L, Vincent-Salomon A, Sastre-Garau X, Burkhard B, Sedlik C, Lantz O, Amigorena S, Piaggio E. Núñez NG, et al. Among authors: perol l. Nat Commun. 2020 Jun 29;11(1):3272. doi: 10.1038/s41467-020-17046-2. Nat Commun. 2020. PMID: 32601304 Free PMC article.
Limitations of IL-2 and rapamycin in immunotherapy of type 1 diabetes.
Baeyens A, Pérol L, Fourcade G, Cagnard N, Carpentier W, Woytschak J, Boyman O, Hartemann A, Piaggio E. Baeyens A, et al. Among authors: perol l. Diabetes. 2013 Sep;62(9):3120-31. doi: 10.2337/db13-0214. Epub 2013 May 13. Diabetes. 2013. PMID: 23670972 Free PMC article.
High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors.
Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J. Perol L, et al. Leuk Lymphoma. 2019 Sep;60(9):2324-2327. doi: 10.1080/10428194.2019.1577414. Epub 2019 Feb 18. Leuk Lymphoma. 2019. PMID: 30773115 No abstract available.
12 results